IO Biotech, Inc. (IOBTQ) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2024 | -$82.35M | -14.8% |
| 2023 | -$71.74M | -20.1% |
| 2022 | -$59.73M | -46.9% |
| 2021 | -$40.65M | -308.3% |
| 2020 | -$9.96M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2024 | -$82.35M | -14.8% |
| 2023 | -$71.74M | -20.1% |
| 2022 | -$59.73M | -46.9% |
| 2021 | -$40.65M | -308.3% |
| 2020 | -$9.96M | — |